張小弟 asked in 健康其他:保健 · 1 decade ago

非常急,拜託大家了~ 需要翻譯,別用翻譯軟體!!

In the United States, the prevalence of iron deficiency in HDpatients receiving ESA therapy is as high as 90% (5).

Irondeficiency leads to inefficient erythropoiesis and is a commoncause of ESA resistance (22).

Treatment of iron deficiency istherefore an essential component of appropriate anemia managementin HD patients.

Intravenous iron therapy replaces ironlost during the HD procedure, enables efficient erythropoiesis,and ameliorates ESA resistance in the setting of iron deficiency,thereby optimizing the use and effects of ESA therapy (7,23–26).

The Kidney Disease Outcomes Quality Initiative anemia guidelinesrecommend IV administration as the preferred route ofiron delivery in HD patients on ESA therapy and recommendthat the goal of therapy should be to achieve and maintainTSAT _20%, CHr _29 pg/cell, and serum ferritin _200 ng/ml(9). Consequently, most HD patients in the United States receiveIV iron to treat iron-deficiency anemia.

2 Answers

Rating
  • 碰碰
    Lv 6
    1 decade ago
    Favorite Answer

    你好,很高興為你解答:

    In the United States,

    在美國,

    the prevalence of iron deficiency in HD patients receiving ESA therapy is as high as 90% (5).

    普遍存在的缺鐵性貧血在血液透析患者接受紅血球生成刺激劑治療高達90 % ( 5 ) 。

    Iron deficiency leads to inefficient erythropoiesis and is a common cause of ESA resistance (22).

    缺鐵導致效率低下的紅細胞,是普通因為紅血球生成刺激劑抵抗( 22 ) 。

    Treatment of iron deficiency is therefore an essential component of appropriate anemia management in HD patients.

    治療缺鐵因此,一個必不可少的適當性組成部分貧血管理血液透析病人。

    Intravenous iron therapy replaces iron lost during the HD procedure,

    靜脈補鐵治療取代血液透析程序中鐵的流失,

    enables efficient erythropoiesis,and ameliorates ESA resistance in the setting of iron deficiency,

    實現高效率紅細胞,和在設置缺鐵改善紅血球生成刺激劑的抵抗,

    thereby optimizing the use and effects of ESA therapy (7,23–26).

    從而紅血球生成刺激劑治療最大限度地利用和影響。

    The Kidney Disease Outcomes Quality Initiative anemia guidelines recommend IV administration as the preferred route of iron delivery in HD patients on ESA therapy

    腎臟疾病的成果質量倡議性貧血準則建議第四行政作為首選紅血球生成刺激劑治療運輸鐵的路線到血液透析病人

    and recommend that the goal of therapy should be to achieve and maintain TSAT _20%,

    和建議治療目的應達到和維持運鐵蛋白飽和度的20%。

    CHr _29 pg/cell, and serum ferritin _200 ng/ml(9).

    CHr _29 pg/cell(這個要問專上醫師),和血清鐵蛋白_200ng/ml(9)。

    Consequently, most HD patients in the United States receive IV iron to treat iron-deficiency anemia.

    因此,大多數血液透析病人在美國接受四鐵治療缺鐵性貧血。

    英文名稱: hemodialysis(HD)

    中文名稱: 血液透析

    名詞解釋: 血液透析就是洗腎:經由打針讓體內血液流出經過一種人工透析器(亦稱人工腎臟),過濾血液中廢物,讓乾淨的血液再流回病人體內,腎臟或永久代替腎臟排泄體內廢物的一種治療方法。

    紅血球生成刺激劑(erythropoiesis-stimulating agent,ESA)

    Transferrin saturation (TSAT)運鐵蛋白飽和度

    Transferrin saturation 正常是20 – 45%;如小於20% 有可能是鐵質缺乏。

    2009-08-21 13:49:26 補充:

    這是醫學翻譯不是普通翻譯, 女孩:") 怎麼把ESA翻成歐空局?更離譜的是怎麼把CHr 翻成人權委員會?

    這種網路翻譯機還是不要用好,畢竟醫學翻譯不像一般翻譯用一般翻譯機就可得出答案的。

    Source(s): Kingnet國家網路醫院+自已+維基百科+榮陽數位化醫學字典。
    • Login to reply the answers
  • 1 decade ago

    在美國,普遍存在的缺鐵性貧血中的HDpatients獲得歐空局的療法是高達90 % ( 5 ) 。

    Irondeficiency導致效率低下的紅細胞,是commoncause電阻歐空局( 22 ) 。

    治療缺鐵istherefore的一個重要組成部分的適當性貧血managementin血液透析病人。

    靜脈補鐵治療取代ironlost期間高清程序,使有效的促紅細胞生成,並改善歐空局的阻力在確定缺鐵,從而最大限度地利用和影響,歐空局療法( 7,23-26 ) 。

    腎臟疾病的成果質量倡議貧血guidelinesrecommend給藥作為首選路線ofiron交貨的血液透析病人的治療和歐空局recommendthat治療的目標應當是實現和maintainTSAT _20 % ,人權委員會_29皮克/細胞,血清鐵蛋白_200毫微克/毫升( 9 ) 。因此,大多數HD病人在美國receiveIV鐵治療缺鐵性貧血。

    希望我的回答有幫助 =]

    • Login to reply the answers
Still have questions? Get your answers by asking now.